West Paces Advisors’s ResMed RMD Stock Holding History

West Paces Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-13	Closed	-$2.53K	–	770
2026 Q2	$2.53K	Buy	+13	New	+$2.69K	﹤0.01%	556
2025 Q2	–	Sell	-2	Closed	-$448	–	487
2025 Q1	$448	Hold	2	–	–	﹤0.01%	536
2024 Q4	$457	Hold	2	–	–	﹤0.01%	526
2024 Q3	$488	Hold	2	–	–	﹤0.01%	516
2024 Q2	$383	Hold	2	–	–	﹤0.01%	539
2024 Q1	$396	Sell	2 -4	-67%	-$733	﹤0.01%	555
2023 Q4	$1.03K	Buy	+6	New	+$922	﹤0.01%	505
2023 Q3	–	Sell	-4	Closed	-$874	–	554
2023 Q2	$874	Hold	4	–	–	﹤0.01%	498
2023 Q1	$876	Buy	4 +1	+33%	+$217	﹤0.01%	517
2022 Q4	$624	Sell	3 -4	-57%	-$879	﹤0.01%	496
2022 Q3	$1.53K	Hold	7	–	–	﹤0.01%	446
2022 Q2	$1.47K	Buy	7 +3	+75%	+$639	﹤0.01%	502
2022 Q1	$970	Buy	+4	New	+$968	﹤0.01%	531
2021 Q3	–	Sell	-108	Closed	-$26.6K	–	628
2021 Q2	$26.6K	Sell	108 -112	-51%	-$23.5K	0.01%	260
2021 Q1	$42.7K	Buy	+220	New	+$44.1K	0.02%	205

Other funds holding RMD

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Aware Super Sydney, Australia $7.51B AUM

Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return

Capital Investment Services of America Milwaukee, Wisconsin $1.09B AUM 8.58% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

West Paces Advisors's RMD Position: Q3 2026 in Review

West Paces Advisors sold out of ResMed (RMD) in Q3 2026, closing a stake of 13 shares — an estimated $2.53K sold.

West Paces Advisors first reported a position in RMD in Q1 2021 and held it in 15 quarters. The position peaked at $42.7K in Q1 2021. 345 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

West Paces Advisors reported no remaining ResMed position as of Q3 2026 after selling out during the quarter.
West Paces Advisors sold 13 ResMed shares in Q3 2026, an estimated $2.53K.
West Paces Advisors first reported a position in ResMed in Q1 2021 and held it in 15 quarters.
West Paces Advisors's ResMed position peaked at $42.7K in Q1 2021.
345 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.